Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
130M
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
49.1M
-
Shares change
-
+6.28M
-
Total reported value, excl. options
-
$94.3M
-
Value change
-
+$11.9M
-
Put/Call ratio
-
0.45
-
Number of buys
-
49
-
Number of sells
-
-17
-
Price
-
$1.92
Significant Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q3 2024
83 filings reported holding PROK - PROKIDNEY CORP. - Ordinary Shares as of Q3 2024.
PROKIDNEY CORP. - Ordinary Shares (PROK) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.1M shares
of 130M outstanding shares and own 37.86% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (14.3M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (12.3M shares), BlackRock, Inc. (6.41M shares), VANGUARD GROUP INC (5.22M shares), GEODE CAPITAL MANAGEMENT, LLC (2.2M shares), Bleichroeder LP (1.85M shares), STATE STREET CORP (1.43M shares), Brown University (1M shares), NORTHERN TRUST CORP (830K shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (750K shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.